Regulus Therapeutics Inc. (RGLS) Weighted Average Number of Shares Outstanding, Diluted 2012 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Regulus Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2012 to 2024.
  • Regulus Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 28.7 M shares, a 70.7% increase year-over-year.
  • Regulus Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 19 M shares, a 24.2% increase from 2022.
  • Regulus Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 15.3 M shares, a 78.1% increase from 2021.
  • Regulus Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 8.57 M shares, a 75.5% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 28.7 M +11.9 M +70.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 19 M +3.7 M +24.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 19.6 M +4.66 M +31.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 19.1 M +4.49 M +30.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 16.8 M +2.25 M +15.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 15.3 M +6.69 M +78.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 15 M +6.27 M +72% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 14.6 M +6.9 M +89.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 14.6 M -56.7 M -79.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 8.57 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 8.7 M -29.4 M -77.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 7.72 M -22.1 M -74.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 71.3 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 38.1 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 29.8 M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q3 2015 52 M +7.13 M +15.9% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-06
Q2 2015 51.1 M +6.27 M +14% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-05
Q3 2014 44.9 M +3.3 M +7.94% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 44.8 M +8.8 M +24.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q3 2013 41.6 M -314 M -88.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 36 M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q3 2012 356 M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.